Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.

Salazar-Vizcaya, Luisa; Keiser, Olivia; Technau, Karl; Davies, Mary-Ann; Haas, Andreas D; Blaser, Nello; Cox, Vivian; Eley, Brian; Rabie, Helena; Moultrie, Harry; Giddy, Janet; Wood, Robin; Egger, Matthias; Estill, Janne (2014). Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study. AIDS, 28(16), pp. 2451-2460. Lippincott Williams & Wilkins 10.1097/QAD.0000000000000446

Preview	Text Salazar AIDS 2014.pdf - Published Version Available under License Publisher holds Copyright. Download (546kB) | Preview
Preview	Text Salazar-Vizcaya AIDS 2014_manuscript.pdf - Accepted Version Available under License Publisher holds Copyright. Download (448kB) | Preview

OBJECTIVES

Many paediatric antiretroviral therapy (ART) programmes in Southern Africa rely on CD4⁺ to monitor ART. We assessed the benefit of replacing CD4⁺ by viral load monitoring.

DESIGN

A mathematical modelling study.

METHODS

A simulation model of HIV progression over 5 years in children on ART, parameterized by data from seven South African cohorts. We simulated treatment programmes with 6-monthly CD4⁺ or 6- or 12-monthly viral load monitoring. We compared mortality, second-line ART use, immunological failure and time spent on failing ART. In further analyses, we varied the rate of virological failure, and assumed that the rate is higher with CD4⁺ than with viral load monitoring.

RESULTS

About 7% of children were predicted to die within 5 years, independent of the monitoring strategy. Compared with CD4⁺ monitoring, 12-monthly viral load monitoring reduced the 5-year risk of immunological failure from 1.6 to 1.0% and the mean time spent on failing ART from 6.6 to 3.6 months; 1% of children with CD4⁺ compared with 12% with viral load monitoring switched to second-line ART. Differences became larger when assuming higher rates of virological failure. When assuming higher virological failure rates with CD4⁺ than with viral load monitoring, up to 4.2% of children with CD4⁺ compared with 1.5% with viral load monitoring experienced immunological failure; the mean time spent on failing ART was 27.3 months with CD4⁺ monitoring and 6.0 months with viral load monitoring. Conclusion: Viral load monitoring did not affect 5-year mortality, but reduced time on failing ART, improved immunological response and increased switching to second-line ART.

Interest & Impact

Downloads

324 since deposited on 01 Apr 2015
17 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item